ArticleFrontiers in endocrinology2026
Melatonin receptor 1 signaling modulates the metabolic response to high-fat diet in female melatonin-proficient mice.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Melatonin plays an important role in the regulation of several physiological functions, including the regulation of circadian rhythms, sleep and reproduction. Recent studies have also reported melatonin signaling via its G-protein coupled receptors (namely MT1 and MT2), affects glucose metabolism, insulin sensitivity, and blood lipid levels. However, most of these studies have been conducted with melatonin-deficient male mice. In the present study, we investigated the effects of a low-fat diet (LFD) and high-fat diet (HFD) on liver biology and transcriptome using melatonin-proficient female mice (C3H-f+/+) and MT1 knockout mice. Our results demonstrate that MT1 deletion alone does not cause notable changes in weight, lipid profile or hepatic lipid accumulation, whereas the combination of MT1 deficiency and HFD exposure results in significant changes in glucose tolerance, serum lipid profiles and lipid accumulation in the liver. In addition, removal of MT1 signaling also induced significant changes in the liver transcriptome that were exacerbated by exposure to HFD. Finally, our data indicate that MT1 deletion was associated with changes in estrogen-related hepatic transcriptional pathways and circulating estradiol levels. These results suggest that MT1 signaling contributes to the metabolic and hepatic response to HFD in female mice. Our study also suggests that these effects may be associated with changes in estrogen-related signaling observed in MT1 KO mice under HFD conditions, although further studies are required to determine causality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.